What is the World Health Organization’s stance on CBD?
The World Health Organization (WHO) is an agency of the United Nations concerned with international public health. It was established in 1948, and is headquartered in Geneva, Switzerland.
What does the WHO say about CBD?
In November of 2017, the World Health Organization Expert Committee on Drug Dependence (ECDD) concluded that cannabidiol (CBD), a compound found in the cannabis plant, has no abuse or dependence potential.
A second report, published in June of 2018, stated that CBD has been demonstrated as an effective treatment for epilepsy in several clinical trials. It also noted that CBD may be a useful treatment for a number of other medical conditions.
The WHO suggested that any reported adverse effects may be the result of drug-drug interactions between CBD and other medications, and said that “to date, there is no evidence of recreational use of CBD or any public health-related problems associated with the use of pure CBD.”
Does that mean that the WHO recommends CBD for medical use?
No, not yet at least. Although the organization has helped to publicize the promising clinical trial results of using CBD to treat epilepsy, it has stopped short of recommending CBD for medical use. The WHO’s stance is that CBD could have some medical use but that more evidence is needed.